Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology (Nasdaq: ALGN) will participate in two upcoming financial conferences. The presentations will be live-streamed on their Investor Relations website, with replays available for three months. The first event is the 32nd Annual Piper Sandler Virtual Healthcare Conference on December 1, 2020, from 1:30 PM to 1:55 PM ET, followed by the 3rd Annual Evercore Virtual ISI HealthCONx Conference on December 2, 2020, from 1:00 PM to 1:45 PM ET. Key speakers include CFO John Morici and Senior Manager Madelyn Homick.
Align Technology is focused on expanding digital orthodontics through its Invisalign doctors, announcing an opportunity to capture a global market of 15 million annual orthodontic case starts, with an additional potential of 500 million consumers. CEO Joe Hogan discussed the company's growth strategy, forecasting a CAGR of over 20% over five years, supported by a robust network of over 189,000 Invisalign doctors. The company continues to invest in its digital platform and iTero scanner technology, aiming to drive further adoption of Invisalign treatments.
Align Technology will host a virtual Investor Day on November 23, 2020, from 8:00 a.m. to 1:00 p.m. Eastern time. The event aims to provide insights into the company's future plans and performance. Interested participants must register in advance at registration link. The meeting will be livestreamed on the company’s website with a replay available for three months.
Align Technology (NASDAQ: ALGN) announced that the International Trade Commission (ITC) modified an earlier ruling regarding an investigation against 3Shape A/S. The ITC acknowledged that 3Shape infringed certain Align patents but invalidated those claims while upholding the validity of two other patents. However, it reversed the finding of indirect infringement. Align expressed disagreement with the ITC's decision and is considering further legal action, aiming to safeguard its intellectual property following significant investments in technology.
Align Technology announced the opening of its 2021 Research Award Program, offering up to $300,000 in funding for clinical and scientific dental research worldwide. Since its inception in 2010, the program has awarded approximately $2 million to advance orthodontics and dentistry. This year, awards will be available for research in the Americas, EMEA, and APAC regions, with a focus on improving patient care. Applications must be submitted by March 5, 2021, and recipients will be notified by June 7, 2021.
Align Technology reported impressive Q3 2020 results with total revenues at $734.1 million, marking a 20.9% increase year-over-year. The GAAP diluted net income per share was $1.76, while non-GAAP amounted to $2.25. Clear Aligner volume soared by 28.7% to 496.1 thousand cases. The operating margin improved to 24.1%, a significant 44.8 points increase sequentially. Align also celebrated 9 million Invisalign patients and launched innovative products enhancing treatment options.
Align Technology has announced the launch of Invisalign G8 with SmartForce Aligner Activation, enhancing treatment predictability for crowding, crossbite, and deep bite cases. Leveraging data from over 9 million Invisalign patients, this innovation optimizes tooth movements. Key features include automatic force application and precision bite ramps to improve treatment outcomes, with a reported 2x improvement in incisor intrusion predictability. Invisalign G8 will be available globally in Q1 2021.
Align Technology has filed a lawsuit against 3Shape for infringing seven additional patents in the U.S. District Court for the Western District of Texas. This lawsuit asserts over 30 patents against 3Shape, following a previous determination by the ITC that 3Shape’s scanners violated Align's patents. Align aims to protect its intellectual property and intends to assess further patent assertions against 3Shape if necessary.
Align Technology, Inc. (Nasdaq: ALGN) will announce its third quarter 2020 financial results on October 21, 2020, after market close at 4:00 p.m. ET. The results will be accessible on the Investor Relations section of their website. A conference call is scheduled for 4:30 p.m. ET to discuss these results, available via audio webcast. An archived replay will be accessible within an hour post-call and will be available for one month. Align Technology specializes in clear aligners, intraoral scanners, and CAD/CAM software, improving patient outcomes through advanced digital dentistry.
Align Technology has reached a significant milestone by treating its 1 millionth patient in the Asia Pacific with the Invisalign system, the leading clear aligner technology. This announcement emphasizes the growing adoption of Invisalign, with over 8 million patients worldwide. The milestone was celebrated by highlighting Ayumu Saito, a 23-year-old Olympic hopeful, as the 1 millionth patient. Align Tech is committed to enhancing patient outcomes through digital orthodontics and has contributed over $1 million to Operation Smile, supporting children and adults born with cleft conditions.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
